CD8A and diabetes mellitus: While Tregs are known to regulate the function and development of CD8 T cells, and in diabetes, Tregs can modulate the migration of CD8 T cells into the pancreatic islets,46–48 they do not appear to play much of a role regulating the CD8+ T-cell–mediated breakdown of the blood–brain barrier in ECM.49